guest ::
Development of radiopharmaceuticals for targeted alpha therapy : Where do we stand?
;
In
Radiotheranostics: from Basic Research to Clinical Application
In
Frontiers in medicine 9, Seiten/Artikel-Nr.:1-16
2022
Online
DOI: 10.3389/fmed.2022.1020188
DOI: 10.18154/RWTH-CONV-251431
URL: https://publications.rwth-aachen.de/record/957385/files/957385.pdf
Einrichtungen
OpenAccess: 
PDF
Dokumenttyp
Journal Article (Review Article)/Contribution to a book
Format
online
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-85145500947
WOS Core Collection: WOS:000907514700001
PubMed: pmid:36619636
OpenAlex: W4312127000
Interne Identnummern
RWTH-CONV-251431
Datensatz-ID: 957385
Beteiligte Länder
Germany, USA
; 
; 
; 
; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF